meta_pixel
Tapesearch Logo
Log in
The Daily 202's Big Idea

AstraZeneca's coronavirus vaccine has lower efficacy than rivals but might prove more helpful

The Daily 202's Big Idea

The Washington Post

Politics, News, Daily News

4.61.1K Ratings

🗓️ 23 November 2020

⏱️ 12 minutes

🧾️ Download transcript

Summary

Plus, President-elect Joe Biden picks Tony Blinken to be his secretary of state, and Israel's prime minister visits Saudi Arabia for the first time.

Transcript

Click on a timestamp to play from that location

0:00.0

Good morning. I'm James Holman from the Washington Post and this is the Daily

0:06.8

202 for Monday, November 23rd. In today's news, Joe Biden picks Tony Blinkin to be his Secretary of State.

0:15.0

The President's legal team is thrown into tumult, as Chris Christie calls them a national embarrassment.

0:21.0

And Israel's Prime minister visits Saudi Arabia for the first time.

0:29.9

But first the big idea. The coronavirus vaccine developed by Oxford University

0:36.3

and the British-Sw Swedish pharmaceutical giant AstraZeneca is up to 90% effective

0:42.1

when administered as a half dose and then a full dose a month later.

0:46.8

And in the trials, no participant who received the vaccine developed a severe case or required hospitalization.

0:54.3

AstraZeneca says in a news release this morning that the vaccine's average efficacy

0:58.0

is 70%, reflecting the disparate results from two different dosing regiments.

1:03.2

When two full doses were given at least one month apart, for example, efficacy fell to 62%.

1:08.8

Now the vaccines from Pfizer and Moderna showed efficacy of about 95% according to data from late

1:15.5

stage trials that those companies released last week. So while the results

1:19.0

released by AstraZeneca indicate slightly lower efficacy, our London correspondent Bill Booth explains that it might actually be more significant

1:26.9

for stopping the spread of the pandemic, because this vaccine can be stored and transported at normal refrigerated conditions for up to six months.

1:37.0

That could make it significantly easier to roll out than Pfizer's vaccine, which has to be stored at negative 70 degrees Celsius or

1:45.1

modernos which is stable and refrigerated conditions for only 30 days and

1:49.3

must be frozen at negative 20 degrees Celsius after that. This one is also

1:54.7

significantly cheaper to manufacture. The cost and distribution elements are

1:58.4

critically important for addressing the pandemic in the developing world.

2:04.0

Moncef Sloi, the chief scientific advisor to the White House's Operation War speed vaccine effort

2:08.6

said Sunday on CNN that about 70% of the American population will need to get vaccinated for true herd

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Washington Post, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Washington Post and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.